AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Gliprip-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Suraksha Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Gliprip-M1 Tablet PR

Metformin-Glipizide combination tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This dual therapy helps regulate blood glucose. These tablets should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with a quick-acting glucose source like sweets or juice. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Gliprip-M1 Tablet PR

No text was provided. Please provide the text you wish me to rephrase.

Uses of Gliprip-M1 Tablet PR

Managing Type 2 Diabetes

Major Benefits of Gliprip-M1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for guidance. Administer Gliprip-M1 Tablet PR with a meal.

Common Side effects of Gliprip-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliprip-M1 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Take Gliprip-M1 Tablet PR with meals.

How Gliprip-M1 Tablet PR works:

Gliprip-M1 Tablet PR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage diabetes. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Gliprip-M1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Gliprip-M1 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Gliprip-M1 Tablet PR are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Gliprip-M1 Tablet PR cautiously, potentially requiring dose modification. Physician consultation is recommended. Gliprip-M1 Tablet PR is contraindicated in those with severely compromised renal function. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliprip-M1 Tablet PR cautiously, potentially requiring dose modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dosage; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Gliprip-M1 Tablet PR :

Should you forget a dose of Gliprip-M1 Tablet PR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Gliprip-M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliprip-M1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Gliprip-M1 Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. If you experience these symptoms, discontinue Gliprip-M1 Tablet PR and seek immediate medical attention.
Gliprip-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Gliprip-M1 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Gliprip-M1 Tablet PR use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Gliprip-M1 Tablet PR can indeed cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. These are more likely if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are taken concurrently. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Gliprip-M1 Tablet PR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Gliprip-M1 Tablet PR
47
MRP 54
13% off